PPARs as Key Mediators in the Regulation of Metabolism and Inflammation

Manuel Vázquez-Carrera; Walter Wahli

doi:10.3390/ijms23095025

PPARs as Key Mediators in the Regulation of Metabolism and Inflammation

Int J Mol Sci. 2022 Apr 30;23(9):5025. doi: 10.3390/ijms23095025.

Authors

Manuel Vázquez-Carrera^{1

2}, Walter Wahli^{3

4

5}

Affiliations

¹ Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, Institute of Biomedicine (IBUB), University of Barcelona, 08007 Barcelona, Spain.
² Spanish Biomedical Research Center in Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, 28029 Madrid, Spain.
³ Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore.
⁴ Center for Integrative Genomics, University of Lausanne, CH-1015 Lausanne, Switzerland.
⁵ Toxalim, INRAE UMR 1331, ENVT, INP-Purpan, University of Toulouse, Paul Sabatier University, F-31027 Toulouse, France.

Abstract

Nuclear receptors (NRs) form a large family of ligand-dependent transcription factors that control the expression of a multitude of genes involved in diverse, vital biological processes [...].

Publication types

Editorial

MeSH terms

Humans
Inflammation* / genetics
Inflammation* / metabolism
Lipid Metabolism
Peroxisome Proliferator-Activated Receptors* / metabolism
Receptors, Cytoplasmic and Nuclear / genetics
Receptors, Cytoplasmic and Nuclear / metabolism
Transcription Factors / metabolism

Substances

Peroxisome Proliferator-Activated Receptors
Receptors, Cytoplasmic and Nuclear
Transcription Factors

Grants and funding

There was no external funding for the preparation of this Editorial.